References

1. Torres MJ, Celik GE, Whitaker P, Atanaskovic-Markovic M, Barbaud A, Bircher A, et al. A EAACI drug allergy interest group survey on how European allergy specialists deal with beta-lactam allergy. Allergy. 2019;74(6):1052-62.
2. Zhou L, Dhopeshwarkar N, Blumenthal KG, Goss F, Topaz M, Slight SP, et al. Drug allergies documented in electronic health records of a large healthcare system. Allergy. 2016;71(9):1305-13.
3. Macy E, Ngor EW. Safely Diagnosing Clinically Significant Penicillin Allergy Using Only Penicilloyl-Poly-Lysine, Penicillin, and Oral Amoxicillin. The Journal of Allergy and Clinical Immunology: In Practice. 2013;1(3):258-63.
4. Demoly P, Adkinson NF, Brockow K, Castells M, Chiriac AM, Greenberger PA, et al. International Consensus on drug allergy. Allergy. 2014;69(4):420-37.
5. Pichler WJ, Hausmann O. Classification of Drug Hypersensitivity into Allergic, p-i, and Pseudo-Allergic Forms. International archives of allergy and immunology. 2016;171(3-4):166-79.
6. Trubiano JA, Adkinson NF, Phillips EJ. Penicillin Allergy Is Not Necessarily Forever. JAMA. 2017;318(1):82-3.
7. Ricci G, Giannetti A, Belotti T, Dondi A, Bendandi B, Cipriani F, et al. Allergy is not the main trigger of urticaria in children referred to the emergency room. J Eur Acad Dermatol Venereol. 2010;24(11):1347-8.
8. Atanasković-Marković M, Gaeta F, Medjo B, Gavrović-Jankulović M, Ćirković-Veličković T, Tmusic V, et al. Non-immediate hypersensitivity reactions to beta-lactam antibiotics in children - our 10-year experience in allergy work-up. Pediatr Allergy Immunol. 2016;27(5):533-8.
9. Macy E, Contreras R. Health care use and serious infection prevalence associated with penicillin ”allergy” in hospitalized patients: A cohort study. J Allergy Clin Immunol. 2014;133(3):790-6.
10. Shenoy ES, Macy E, Rowe T, Blumenthal KG. Evaluation and management of penicillin allergy: A review. JAMA. 2019;321(2):188-99.
11. Penicillin Allergy in Antibiotic Resistance W. Penicillin Allergy Testing Should Be Performed Routinely in Patients with Self-Reported Penicillin Allergy. J Allergy Clin Immunol Pract. 2017;5(2):333-4.
12. Torres MJ, Romano A, Celik G, Demoly P, Khan DA, Macy E, et al. Approach to the diagnosis of drug hypersensitivity reactions: similarities and differences between Europe and North America. Clin Transl Allergy. 2017;7:7.
13. Macy E, Ensina LF. Controversies in Allergy: Is Skin Testing Required Prior to Drug Challenges? J Allergy Clin Immunol Pract. 2019;7(2):412-7.
14. Sousa-Pinto B, Blumenthal KG, Macy E, Bavbek S, Benic MS, Alves-Correia M, et al. Diagnostic testing for penicillin allergy: A survey of practices and cost perceptions. Allergy. 2020;75(2):436-41.
15. Mayorga C, Doña I, Perez-Inestrosa E, Fernández DT, Torres JM. The Value of In Vitro Tests to Diminish Drug Challenges. International Journal of Molecular Sciences. 2017;18(6).
16. Mayorga C, Celik G, Rouzaire P, Whitaker P, Bonadonna P, Rodrigues-Cernadas J, et al. In vitro tests for drug hypersensitivity reactions: an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy. 2016;71(8):1103-34.
17. Blumenthal KG, Li Y, Banerji A, Yun BJ, Long AA, Walensky RP. The Cost of Penicillin Allergy Evaluation. The journal of allergy and clinical immunology In practice. 2018;6(3):1019-27.e2.
18. Confino-Cohen R, Rosman Y, Meir-Shafrir K, Stauber T, Lachover-Roth I, Hershko A, et al. Oral Challenge without Skin Testing Safely Excludes Clinically Significant Delayed-Onset Penicillin Hypersensitivity. J Allergy Clin Immunol Pract. 2017;5(3):669-75.
19. Tucker MH, Lomas CM, Ramchandar N, Waldram JD. Amoxicillin challenge without penicillin skin testing in evaluation of penicillin allergy in a cohort of Marine recruits. J Allergy Clin Immunol Pract. 2017;5(3):813-5.
20. Mustafa SS, Conn K, Ramsey A. Comparing Direct Challenge to Penicillin Skin Testing for the Outpatient Evaluation of Penicillin Allergy: A Randomized Controlled Trial. The Journal of Allergy and Clinical Immunology: In Practice. 2019;7(7):2163-70.
21. Brockow K, Przybilla B, Aberer W, Bircher AJ, Brehler R, Dickel H, et al. Guideline for the diagnosis of drug hypersensitivity reactions: S2K-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Dermatological Society (DDG) in collaboration with the Association of German Allergologists (AeDA), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Contact Dermatitis Research Group (DKG), the Swiss Society for Allergy and Immunology (SGAI), the Austrian Society for Allergology and Immunology (OGAI), the German Academy of Allergology and Environmental Medicine (DAAU), the German Center for Documentation of Severe Skin Reactions and the German Federal Institute for Drugs and Medical Products (BfArM). Allergo J Int. 2015;24(3):94-105.
22. Wurpts G, Aberer W, Dickel H, Brehler R, Jakob T, Kreft B, et al. S2k-Leitlinie: Diagnostik bei Verdacht auf eine Betalaktamantibiotika-Überempfindlichkeit. Allergo J. 2019;28:121-51.
23. Zidarn M, Silar M, Vegnuti M, Korosec P, Kosnik M. The specificity of tests for anti-beta-lactam IgE antibodies declines progressively with increase of total serum IgE. Wiener klinische Wochenschrift. 2009;121(9-10):353-6.
24. Cornejo-Garcia JA, Gueant-Rodriguez RM, Torres MJ, Blanca-Lopez N, Tramoy D, Romano A, et al. Biological and genetic determinants of atopy are predictors of immediate-type allergy to betalactams, in Spain. Allergy. 2012;67(9):1181-5.
25. Vultaggio A, Virgili G, Gaeta F, Romano A, Maggi E, Matucci A. High serum β-lactams specific/total IgE ratio is associated with immediate reactions to β-lactams antibiotics. PloS one. 2015;10(4):e0121857-e.
26. Visentin M, Lenggenhager D, Gai Z, Kullak-Ublick GA. Drug-induced bile duct injury. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2018;1864(4, Part B):1498-506.
27. Brockow K, Aberer W, Atanaskovic-Markovic M, Bavbek S, Bircher A, Bilo B, et al. Drug allergy passport and other documentation for patients with drug hypersensitivity - An ENDA/EAACI Drug Allergy Interest Group Position Paper. Allergy. 2016;71(11):1533-9.
28. Fellinger C, Hemmer W, Wöhrl S, Sesztak-Greinecker G, Jarisch R, Wantke F. Clinical characteristics and risk profile of patients with elevated baseline serum tryptase. Allergol Immunopathol (Madr). 2014;42(6):544-52.
29. Wöhrl S, Vigl K, Stingl G. Patients with drug reactions - is it worth testing? Allergy. 2006;61(8):928-34.
30. Mayorga C, Ebo DG, Lang DM, Pichler WJ, Sabato V, Park MA, et al. Controversies in drug allergy: In vitro testing. J Allergy Clin Immunol. 2019;143(1):56-65.
31. Salas M, Fernandez-Santamaria R, Mayorga C, Barrionuevo E, Ariza A, Posadas T, et al. Use of the Basophil Activation Test May Reduce the Need for Drug Provocation in Amoxicillin-Clavulanic Allergy. J Allergy Clin Immunol Pract. 2018;6(3):1010-8.e2.
32. Diaferio L, Chiriac AM, Leoni MC, Castagnoli R, Caimmi S, Miniello VL, et al. Skin tests are important in children with beta-lactam hypersensitivity, but may be reduced in number. Pediatr Allergy Immunol. 2019;30(4):462-8.
33. Tannert LK, Mortz CG, Skov PS, Bindslev-Jensen C. Positive Skin Test or Specific IgE to Penicillin Does Not Reliably Predict Penicillin Allergy. J Allergy Clin Immunol Pract. 2017;5(3):676-83.
34. Mori F, Liccioli G, Piccorossi A, Sarti L, Barni S, Giovannini M, et al. The Diagnosis of Ceftriaxone Hypersensitivity in a Paediatric Population. International archives of allergy and immunology. 2019;178(3):272-6.
35. Romano A, Gaeta F, Valluzzi RL, Alonzi C, Viola M, Bousquet PJ. Diagnosing hypersensitivity reactions to cephalosporins in children. Pediatrics. 2008;122(3):521-7.
36. Messaad D, Sahla H, Benahmed S, Godard P, Bousquet J, Demoly P. Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann Intern Med. 2004;140(12):1001-6.
37. Kränke B, Aberer W, Egger C, Hawranek T, Reider N, Volc-Platzer B, et al. Leitlinie der Arbeitsgruppe Allergologie der ÖGDV – Provokationstestungen zur Abklärung von unerwünschten Arzneireaktionen an Haut und Schleimhäuten. Wiener klinische Wochenschrift. 2011;123(19-20):585-91.
38. Wöhrl S. NSAID hypersensitivity – recommendations for diagnostic work up and patient management. Allergo Journal International. 2018;27(4):114-21.
39. Iammatteo M, Ferastraoaru D, Koransky R, Alvarez-Arango S, Thota N, Akenroye A, et al. Identifying Allergic Drug Reactions Through Placebo-Controlled Graded Challenges. J Allergy Clin Immunol Pract. 2017;5(3):711-7.e2.
40. Demoly P, Romano A, Botelho C, Bousquet-Rouanet L, Gaeta F, Silva R, et al. Determining the negative predictive value of provocation tests with beta-lactams. Allergy. 2010;65(3):327-32.
41. World Health Report. Geneva, Switzerland: World Health Organization; 2000. Available from: https://www.who.int/healthinfo/paper30.pdf.
42. Blumenthal KG, Peter JG, Trubiano JA, Phillips EJ. Antibiotic allergy. The Lancet. 2019;393(10167):183-98.
43. Zagursky RJ, Pichichero ME. Cross-reactivity in beta-Lactam Allergy. J Allergy Clin Immunol Pract. 2018;6(1):72-81 e1.